# OnCo record trophimmun (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/trophimmun/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "trophimmun", "NCT03135769" ;
  schema:name "TROPHIMMUN"@en ;
  schema:alternateName "69HCL16_0123"@en ;
  schema:description "TROPHIMMUN was the first immunotherapy trial in gestational trophoblastic disease, a rare tumour that arises from a pregnancy; the PD-L1 antibody avelumab cured about half of the women whose disease had stopped responding to single-drug chemotherapy, with mild side effects and a healthy pregnancy afterwards in one patient."@en ;
  schema:url <https://onco.cc/trials/trophimmun/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03135769> ;
  onco:status "positive" ;
  onco:tag "soc-trials" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/low-risk-gtn/>, <https://onco.cc/cancers/gestational-trophoblastic/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/avelumab/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-trophimmun-avelumab-chemoresistant-gtn-you-jco-2020/> .